Avanos Medical [AVNS] vs Establishment Labs [ESTA] Detailed Stock Comparison

Avanos Medical Inc.

NYSE
Loading...

Establishment Labs Holdings Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Avanos Medical Inc. wins in 15 metrics, Establishment Labs Holdings Inc. wins in 4 metrics, with 0 ties. Avanos Medical Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Avanos Medical Inc. Establishment Labs Holdings Inc. Better
P/E Ratio (TTM) 34.37 -37.89 Avanos Medical Inc.
Price-to-Book Ratio 1.47 79.68 Avanos Medical Inc.
Debt-to-Equity Ratio 16.59 1,123.15 Avanos Medical Inc.
PEG Ratio -0.34 0.41 Establishment Labs Holdings Inc.
EV/EBITDA 21.79 -70.21 Avanos Medical Inc.
Profit Margin (TTM) -10.40% -24.19% Avanos Medical Inc.
Operating Margin (TTM) 1.99% -6.08% Avanos Medical Inc.
EBITDA Margin (TTM) 1.99% N/A N/A
Return on Equity -9.08% -133.25% Avanos Medical Inc.
Return on Assets (TTM) 0.87% -6.93% Avanos Medical Inc.
Free Cash Flow (TTM) $43.10M $-57.61M Avanos Medical Inc.
1-Year Return 106.28% 119.39% Establishment Labs Holdings Inc.
Price-to-Sales Ratio (TTM) 1.64 8.92 Avanos Medical Inc.
Enterprise Value $1.19B $2.07B Establishment Labs Holdings Inc.
EV/Revenue Ratio 1.69 9.79 Avanos Medical Inc.
Gross Profit Margin (TTM) 47.54% 70.46% Establishment Labs Holdings Inc.
Revenue per Share (TTM) $15 $7 Avanos Medical Inc.
Earnings per Share (Diluted) $-1.57 $-1.72 Avanos Medical Inc.
Beta (Stock Volatility) 1.05 1.08 Avanos Medical Inc.
Short % of Float 6.25% 22.26% Avanos Medical Inc.

Avanos Medical Inc. vs Establishment Labs Holdings Inc. Stock Performance Analysis

Loading Price Chart...

AVNS
ESTA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Avanos Medical Inc.0.00%-0.16%1.01%80.61%110.46%123.26%
Establishment Labs Holdings Inc.2.52%12.52%28.06%32.66%16.91%22.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Avanos Medical Inc.106.28%-2.50%-37.21%-22.48%-35.57%-35.57%
Establishment Labs Holdings Inc.119.39%25.90%5.07%211.25%211.25%211.25%

Performance & Financial Health Analysis: Avanos Medical Inc. vs Establishment Labs Holdings Inc.

MetricAVNSESTA
Market Information
Market Cap i$1.15B$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,796,924451,437
90 Day Avg. Volume i1,631,798478,309
Last Close$24.96$84.21
52 Week Range$9.30 - $25.49$33.35 - $86.00
% from 52W High-2.08%-2.08%
All-Time High$72.96 (Sep 03, 2018)$93.80 (Apr 18, 2022)
% from All-Time High-65.79%-10.22%
Growth Metrics
Quarterly Revenue Growth0.01%0.45%
Quarterly Earnings Growth0.01%0.45%
Financial Health
Profit Margin (TTM) i-0.10%-0.24%
Operating Margin (TTM) i0.02%-0.06%
Return on Equity (TTM) i-0.09%-1.33%
Debt to Equity (MRQ) i16.591,123.15
Cash & Liquidity
Book Value per Share (MRQ)$16.75$0.80
Cash per Share (MRQ)$1.93$2.58
Operating Cash Flow (TTM) i$74.70M$-50,890,000
Levered Free Cash Flow (TTM) i$46.01M$-41,574,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Avanos Medical Inc. vs Establishment Labs Holdings Inc.

MetricAVNS (Apr 24, 2026)ESTA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i34.37-37.89
Forward P/E i19.71316.35
PEG Ratio i-0.340.41
Price to Sales (TTM) i1.648.92
Price to Book (MRQ) i1.4779.68
Market Capitalization
Market Capitalization i$1.15B$1.91B
Enterprise Value i$1.19B$2.07B
Enterprise Value Metrics
Enterprise to Revenue i1.699.79
Enterprise to EBITDA i21.79-70.21
Risk & Other Metrics
Beta i1.051.08
Book Value per Share (MRQ) i$16.75$0.80

Financial Statements Comparison: Avanos Medical Inc. vs Establishment Labs Holdings Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAVNS (2025)ESTA (2025)
Revenue/Sales i701.20M211.08M
Cost of Goods Sold i347.30M64.77M
COGS % of Revenue i49.5%30.7%
Gross Profit i353.90M146.31M
Gross Margin i50.5%69.3%
Research & Development i23.30M20.25M
Operating Income (EBIT) i15.40M-39.01M
Operating Margin i2.2%-18.5%
EBITDA i57.50M-22.29M
EBITDA Margin i8.2%-10.6%
Pre-Tax Income i-66.20M-58.02M
Pre-Tax Income % of Revenue i-9.4%-27.5%
Income Tax i6.70M-6.96M
Income Tax % of Revenue i1.0%-3.3%
Net Income (Profit) i-72.90M-51.06M
Profit Margin i-10.4%-24.2%

Balance Sheet & Liquidity Metrics

MetricAVNS (2025)ESTA (2025)
Cash & Equivalents i89.80M75.57M
Total Current Assets i355.40M249.94M
Total Current Assets % of Revenue i50.7%118.4%
Total Current Liabilities i165.20M82.14M
Total Current Liabilities % of Revenue i23.6%38.9%
Long-Term Debt i110.70M250.34M
Long-Term Debt % of Revenue i15.8%118.6%
Total Shareholders Equity i778.20M23.55M
Retained Earnings i-779.90M-495.76M
Retained Earnings % of Revenue i-111.2%-234.9%
Property, Plant & Equipment i27.60M4.34M

Cash Flow Statement Comparison

MetricAVNS (2025)ESTA (2025)
Operating Cash Flow i10.30M-50.78M
Operating Cash Flow % of Revenue i1.5%-24.1%
Capital Expenditures iN/A-6.05M
Free Cash Flow i43.10M-57.61M
FCF Margin i6.1%-27.3%
Debt Repayment i-34.40M-1.02M
Common Stock Repurchase i-3.30MN/A

Short Interest & Institutional Ownership Analysis

MetricAVNSESTA
Shares Short i2.17M5.22M
Short Ratio i3.759.90
Short % of Float i6.25%22.26%
Shares Outstanding i46.46M29.30M
Float Shares i42.02M19.22M
% Held by Insiders i4.79%10.16%
% Held by Institutions i98.76%102.08%
% Held by Public i-3.55%-12.24%

Dividend Analysis & Yield Comparison: Avanos Medical Inc. vs Establishment Labs Holdings Inc.

MetricAVNSESTA
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A